Literature DB >> 4594316

Treatment of episcleritis. A double-blind trial comparing betamethasone 0.1 per cent, oxyphenbutazone 10 per cent, and placebo eye ointments.

P G Watson, D A McKay, R S Clemett, P Wilkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4594316      PMCID： PMC1215234          DOI： 10.1136/bjo.57.11.866

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  1 in total

1.  Double-blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone.

Authors:  P G Watson; D J Lobascher; D W Sabiston; E Lewis-Faning; P D Fowler; B R Jones
Journal:  Br J Ophthalmol       Date:  1966-08       Impact factor: 4.638
  1 in total
  2 in total

1.  Scleritis and episcleritis.

Authors:  P G Watson; S S Hayreh
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

2.  Prostaglandins, nonsteroidal anti-inflammatory agents and eye disease.

Authors:  S M Podos
Journal:  Trans Am Ophthalmol Soc       Date:  1976
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.